While the RAD51 inhibitors synergized with WEE1 inhibition, no apparent synergistic effect was observed when combined with ATRi or DNA-PKi in MDA-MB-436 breast cancer cells (Figure 5C). The gene discussed is WEE1; the disease is breast cancer.